Search results
Results from the WOW.Com Content Network
CHES (N-cyclohexyl-2-aminoethanesulfonic acid) is a buffering agent. CHES buffers have a useful range of pH 8.6–10. CHES buffers have a useful range of pH 8.6–10. [ 1 ]
Cyclohexylamine is an organic compound, belonging to the aliphatic amine class. It is a colorless liquid, although, like many amines, samples are often colored due to contaminants.
Urea, also known as carbamide-containing cream, [clarification needed] is used as a medication and applied to the skin to treat dryness and itching such as may occur in psoriasis, dermatitis, or ichthyosis. [1] [2] [3] It may also be used to soften nails. [3] In adults side effects are generally few. [4] It may occasionally cause skin ...
Celadrin is an over-the-counter medication marketed as a topical analgesic. It is a cream that is used for muscle and joint pains including osteoarthritis , strains, bruises, and sprains. [ 1 ] The active ingredient is menthol [ 2 ] and it also contains cetylated and esterified fatty acids .
Tapinarof 1% cream once daily was superior to vehicle control in reducing the severity of plaque psoriasis over a period of 12 weeks and having a favorable safety profile in the treatment of psoriatic patients. [10] [15]
A container with cream. Topical cream formulation is an emulsion semisolid dosage form that is used for skin external application. Most of the topical cream formulations contain more than 20 per cent of water and volatiles and/or less than 50 per cent of hydrocarbons, waxes, or polyethylene glycols as the vehicle for external skin application. [1]
CAPS is the common name for 3-(Cyclohexylamino)-1-propanesulfonic acid, a chemical used as buffering agent in biochemistry. The similar substance N-cyclohexyl-2-hydroxyl-3-aminopropanesulfonic acid (CAPSO) is also used as buffering agent in biochemistry. Its useful pH range is 9.7-11.1.
Tavaborole, sold under the brand name Kerydin, is a topical antifungal medication for the treatment of onychomycosis, a fungal infection of the nail and nail bed with a complete clearance rate of 6-7% and partial clearance rate of 23-24% in individuals whose “infection border does not reach the cuticle at the base of the large toenail.” [1] Tavaborole was approved by the US FDA in July ...